Stay updated with breaking news from Amyloid ratio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration or FDA granted marketing authorization for the first in vitro diagnostic test for early detection of amyloid plaques associated with ....
The U.S. Food and Drug Administration granted marketing clearance to a blood test designed to detect amyloid plaques associated with Alzheimer's disease. ....
The Lumipulse G β-Amyloid Ratio (1-42/1-40) test is available at clinical laboratories nationwide for adult patients aged 55 years and older who are presenting with cognitive impairment and being evaluated for Alzheimer’s disease and other causes of cognitive decline. ....